Clinical Research Frequently Asked Questions

clinical researchThe Rivergate Dermatology Clinical Research Center is proud to provide clinical trials for a range of dermatologic conditions and patients in Middle Tennessee. Our goal is to keep our patients’ needs at the forefront, while helping to advance dermatology treatment options through high-quality research.

The research center is under the direct supervision of Dr. Keith Loven and includes our team of experienced doctors, nurses and medical professionals. Our team is committed to maintaining specialized training, certification and continuing education to ensure our research center provides the highest level of care to our patients. We know you may have some questions about our dermatology research trials, so we’ve answered a few of our most frequently asked questions below.

Why should I participate in a research trial?

Because we have access to treatments not yet available on the current market, we can offer medications that can help treat your skin disease better than your current regimen. If you qualify, you will receive medical care related to the trial and possible investigational treatment at no charge, regardless of your insurance coverage. Participants are also often compensated for time and travel expenses from the trial.

Our goal is to provide research on a range of dermatologic conditions, which can help future generations. By conducting our research, we can help find treatment for those with skin conditions in the future.

Are the trials FDA-approved?

Our trials are for treatments not yet approved by the FDA. This is so we can help add to the research done on these medications before they go to the market. When the treatment is ready for the market, it will be tested for FDA approval at that time.

How many trials has Rivergate Dermatology Clinical Research Center conducted?

Dr. Loven has been conducting state-of-the-art clinical research for almost 30 years. During this time, our research center has performed more than 100 trials.

What types of trials does the Research Center offer?

Our Research Center offers a variety of Phase II, III and IV interventional clinical trials related to both common and rare diseases of the skin. Most commonly, our dermatology clinical trials are for those with skin conditions such as:

  • Rosacea
  • Eczema
  • Hidradenitis Supperativa
  • Psoriasis
  • Acne
  • Vitiligo
  • Alopecia
  • Actinic Keratosis

 

How do the trials work? Will I be monitored during the trial?

When you participate in one of our dermatology clinical trials, you can expect to receive continual monitoring and support from our skilled research teams. The sponsor of the trial will cover all costs, so the trial will be at no cost to you. You will be screened first to see if you qualify at an initial screening appointment. Once you qualify, you will receive the medication and be monitored closely throughout the trial.  

How often will I have appointments while participating?

Your appointments will usually be scheduled once a month for the duration of the trial.

Can I participate in more than one trial?

 No, you can only participate in one trial. This is to ensure that our research and data are reliable and effective for each individual trial.

How long do the trials usually last?

 While some trial lengths may vary, typically the trials are conducted over one year.

Are there risks in participating?

As with any medication, there is always the risk of side effects. However, we will discuss potential risks and side effects with you upfront. This will happen with the research staff at your initial screening.

What if I have adverse side effects? Does the Research Center cover treatment costs?

 The trial’s sponsor will cover all costs associated with the research trial.

What are the Research Center’s hours?

We typically see our research patients on Monday and Thursday at our Rivergate office, located at 201 Bluebird Drive in Goodlettsville.

 

Still have questions? No problem! Please visit lovenderm.com/research or call 615.859.7546, ext. 4  for more information.